Is Davunetide FDA approved?

Davunetide is investigational and not FDA approved. It is discussed for research and educational purposes only, not as medical guidance.

Is Leu-Enkephalin FDA approved?

Leu-Enkephalin is not evaluated or approved by the FDA. It is discussed for research and educational purposes only, not as medical guidance.

How is Davunetide administered in research settings?

In research settings, Davunetide is typically administered via the intranasal or subcutaneous routes. PeptideBase does not provide dosing or administration instructions.

How is Leu-Enkephalin administered in research settings?

In research settings, Leu-Enkephalin is typically administered via the subcutaneous or intranasal routes. PeptideBase does not provide dosing or administration instructions.

Home›Research›Compare›Davunetide vs Leu-Enkephalin

Peptide Comparison

Davunetide vs Leu-Enkephalin

Q: What is the difference between Davunetide and Leu-Enkephalin?

Davunetide: Stabilizes microtubules by interacting with tubulin and microtubule-associated proteins. Activates SIRT1, reduces amyloid-β toxicity, and enhances synaptic plasticity. Protects against tau hyperphosphorylation. Leu-Enkephalin: Binds delta and mu opioid receptors in the CNS and periphery. Modulates pain signal transmission in dorsal horn neurons.

Both are Neuro & Cognitive peptides.

Davunetide

NAP

CognitiveInvestigationalResearch Only

No providers listed yet

Full Davunetide profile →

Leu-Enkephalin

Leucine enkephalin

RecoveryNot EvaluatedResearch Only

No providers listed yet

Full Leu-Enkephalin profile →

Bottom line

Davunetide carries stronger published evidence (RCT, 3 key studies) than Leu-Enkephalin (Cohort study, 2); both are research compounds.

Quick Verdict

Davunetide

Evidence

Clinical

Leu-Enkephalin

Evidence

Observational

Which One Should You Choose?

Your goal	Better option
Stronger clinical evidence	Davunetide
Further along in FDA review	Davunetide

Research summary only — not medical advice. Consult a qualified provider before making any decisions.

Side-by-Side Comparison

Davunetide

Leu-Enkephalin

Mechanism Family

Neuro & Cognitive

Half-life

—

FDA Status

investigational

not evaluated

Admin Routes

intranasal, subcutaneous

subcutaneous, intranasal

Availability

Research Only

Providers

None listed

Research Evidence

Davunetide

ClinicalRCT · 3 key studies · most recent 2026

Leu-Enkephalin

ObservationalCohort study · 2 key studies · most recent 2026

Research Citations

Davunetide

Cohort2026 · Epilepsy Res

Microtubule-stabilizing drugs suppress convulsions in a C. elegans model of CAMSAP disorders.

RCT2013 · Neuropsychopharmacology

Effects of davunetide on N-acetylaspartate and choline in dorsolateral prefrontal cortex in patients with sch…

RCT2011 · Schizophrenia Research

Effect of the neuroprotective peptide davunetide (AL-108) on cognition and functional capacity in schizophren…

Leu-Enkephalin

Cohort2026 · Drug Deliv Transl Res

Combining Leu-enkephalin nanomedicines with enkephalinase inhibitors: a promising painkiller strategy?

Animal1986 · Brain Research

Comparison of the antinociceptive action of mu and delta opioid receptor ligands in the periaqueductal gray m…

About Davunetide

Stabilizes microtubules by interacting with tubulin and microtubule-associated proteins. Activates SIRT1, reduces amyloid-β toxicity, and enhances synaptic plasticity. Protects against tau hyperphosphorylation.

Research Areas

neuroprotectiontau stabilizationcognitive enhancementmemorysynaptic plasticity

About Leu-Enkephalin

Binds delta and mu opioid receptors in the CNS and periphery. Modulates pain signal transmission in dorsal horn neurons. Also activates opioid receptors on immune cells, influencing cytokine production and immune cell trafficking.

Research Areas

pain modulationanti-inflammatoryimmune modulation

Safety Profile

Information below reflects published research data only — not medical advice. Consult a qualified provider before use.

Davunetide

No established clinical contraindications. This is an investigational compound with limited human data and has not been evaluated by the FDA for safety in this context. Consult a qualified clinician.

Leu-Enkephalin

No established clinical contraindications. This is an investigational compound with limited human data and has not been evaluated by the FDA for safety in this context. Consult a qualified clinician.

Find Providers

Where to source these peptides

Providers offering

Davunetide

Browse directory →

Providers offering

Leu-Enkephalin

Browse directory →

PeptideBase lists providers for educational research purposes only. Always consult a qualified healthcare professional before obtaining or using any peptide.

More Neuro & Cognitive Comparisons

Browse all peptides →

Educational research tools — not medical advice.